Catalyst OrthoScience Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
46
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$20M
- Investors
-
8
Catalyst OrthoScience General Information
Description
Developer of a shoulder replacement system designed to make orthopedic surgery less invasive and more efficient. The company's system is fixed without a stem to preserve as much strong, healthy bone as possible, replacing traditional shoulder implants which required removal of the top of the humerus so a stem could be inserted down into the bone canal, enabling patients to get access to a precisely less-invasive alternative method of shoulder implant placement.
Contact Information
Website
www.catalystortho.comCorporate Office
- 14710 Tamiami Trail North
- Suite 102
- Naples, FL 34110
- United States
Corporate Office
- 14710 Tamiami Trail North
- Suite 102
- Naples, FL 34110
- United States
Catalyst OrthoScience Timeline
Catalyst OrthoScience Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC | 10-Sep-2024 | $20M | Completed | Generating Revenue | ||
| 7. Later Stage VC (Series E) | 07-Sep-2023 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series D) | 04-Aug-2021 | Completed | Generating Revenue | |||
| 5. Debt - PPP | 10-Apr-2020 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series C1) | 14-May-2019 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series C) | 04-Dec-2017 | Completed | Generating Revenue | |||
| 2. Grant | 04-Nov-2016 | $100K | $3.3M | Completed | Startup | |
| 1. Early Stage VC (Series A) | 15-Aug-2016 | $3.3M | $3.3M | Completed | Startup |
Catalyst OrthoScience Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series E-3 | ||||||||
| Series E-2 | ||||||||
| Series E-1 | ||||||||
| Series D | ||||||||
| Series C1 | ||||||||
| Series C | ||||||||
| Series B | 1,585,000 | $0.001000 | $0.03 | $0.03 | 1x | $0.03 | 0.23% | |
| Series A | 13,423,530 | $0.001000 | $0.24 | $0.24 | 1x | $0.14 | 3.48% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Catalyst OrthoScience Comparisons
Industry
Financing
Details
Catalyst OrthoScience Competitors (11)
One of Catalyst OrthoScience’s 11 competitors is Acumed, a Private Equity-Backed company based in Hillsboro, OR.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Acumed | Private Equity-Backed | Hillsboro, OR | ||||
| NUsurface | Venture Capital-Backed | Memphis, TN | ||||
| Shalby Advanced Technologies | Formerly PE-Backed | El Dorado Hills, CA | ||||
| Graham Medical Technologies | Corporate Backed or Acquired | Macomb, MI | ||||
| Conventus Flower Orthopedics | Venture Capital-Backed | Horsham, PA |
Catalyst OrthoScience Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Catalyst OrthoScience Patents
Catalyst OrthoScience Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-D1048403-S1 | Arthroplasty prosthesis | Active | 04-Feb-2023 | ||
| AU-2023263401-A1 | Bone implants, systems, and methods | Pending | 27-Apr-2022 | ||
| EP-4514276-A1 | Bone implants, systems, and methods | Pending | 27-Apr-2022 | ||
| US-20230106745-A1 | Tendon repair system | Pending | 06-Oct-2021 | ||
| EP-4412544-A1 | Tendon repair system | Pending | 06-Oct-2021 | A61F2/0811 |
Catalyst OrthoScience Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Catalyst OrthoScience Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Bridge Bank | Corporation | Minority | ||
| Lateral Capital Management | Venture Capital | Minority | ||
| Angel (individual) | Minority | |||
| RC Capital (Cincinnati) | Growth/Expansion | Minority | ||
| Mutual Capital Partners | Venture Capital | Minority |
Catalyst OrthoScience FAQs
-
When was Catalyst OrthoScience founded?
Catalyst OrthoScience was founded in 2014.
-
Where is Catalyst OrthoScience headquartered?
Catalyst OrthoScience is headquartered in Naples, FL.
-
What is the size of Catalyst OrthoScience?
Catalyst OrthoScience has 46 total employees.
-
What industry is Catalyst OrthoScience in?
Catalyst OrthoScience’s primary industry is Therapeutic Devices.
-
Is Catalyst OrthoScience a private or public company?
Catalyst OrthoScience is a Private company.
-
What is Catalyst OrthoScience’s current revenue?
The current revenue for Catalyst OrthoScience is .
-
How much funding has Catalyst OrthoScience raised over time?
Catalyst OrthoScience has raised $67.5M.
-
Who are Catalyst OrthoScience’s investors?
Bridge Bank, Lateral Capital Management, , RC Capital (Cincinnati), and Mutual Capital Partners are 5 of 8 investors who have invested in Catalyst OrthoScience.
-
Who are Catalyst OrthoScience’s competitors?
Acumed, NUsurface, Shalby Advanced Technologies, Graham Medical Technologies, and Conventus Flower Orthopedics are some of the 11 competitors of Catalyst OrthoScience.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
